Literature DB >> 2857460

Non-A, non-B hepatitis and intravenous immunoglobulin.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2857460

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

Review 1.  Viral contamination of monoclonal antibody preparations: potential problems and possible solutions.

Authors:  C Harbour; G Woodhouse
Journal:  Cytotechnology       Date:  1990-07       Impact factor: 2.058

2.  Intravenous immune globulin use in children. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1992-01-15       Impact factor: 8.262

Review 3.  Non-A, non-B hepatitis: dead ends or new horizons?

Authors:  S A Iwarson
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-17

Review 4.  Intravenous immunoglobulin in neurological disease: a specialist review.

Authors:  C M Wiles; P Brown; H Chapel; R Guerrini; R A C Hughes; T D Martin; P McCrone; J Newsom-Davis; J Palace; J H Rees; M R Rose; N Scolding; A D B Webster
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

5.  Safety of intravenous immunoglobulin treatment.

Authors:  H I Atrah; R J Crawford; B C Dow; R Mitchell
Journal:  J Clin Pathol       Date:  1985-10       Impact factor: 3.411

Review 6.  Human Immunoglobulins for intravenous use and hepatitis C viral transmission.

Authors:  H B Slade
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

Review 7.  Intravenous immune globulin in primary immunodeficiency.

Authors:  M Haeney
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

8.  HCV infection in patients with primary defects of immunoglobulin production.

Authors:  I Quinti; F Pandolfi; R Paganelli; D el Salman; A Giovannetti; R Rosso; A Oliva; L Rainaldi; F Aiuti
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

9.  A prospective controlled crossover trial of a new heat-treated intravenous immunoglobulin.

Authors:  S R Zuhrie; A D Webster; R Davies; A C Fay; T B Wallington
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

10.  Intravenous gammaglobulin for immunodeficiency: report from The European Group for Immunodeficiencies (EGID).

Authors: 
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.